glp-1 insulin resistance Glucagon-like peptide 1 (GLP-1) Can GLP-1s 'Reset Insulin' Resistance?

The true opportunity lies not simply in responding to the current GLP-1 wave, but in anticipating its evolution and the broader transformation of our approach to metabolic health

Aids in wound healing and tissue repair

Common consequences include: Weight gain or difficulty losing weight Fatigue and low energy Insulin resistance Constipation, dry skin, and cold intolerance Depression or brain fog Notably, thyroid dysfunction can mask or worsen metabolic conditions like obesity, insulin resistance, and prediabetesthe very issues GLP-1 drugs aim to address

The compatibility assessment applies to the entire GLP-1 receptor agonist class, including semaglutide, tirzepatide, and liraglutide